Substituted quinoxalines as sodium channel modulators
US9139529B2 · kind B2 · utility
21Cited by
4References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 29, 2014 |
| Grant date | Sep 22, 2015 |
| Priority date | — |
| Expiry date | Jan 29, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of formula I or pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels:The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders, including pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.